Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The short answer for Montana operators
Behavioral health operators should respond to Blue Cross Blue Shield of Montana’s E/M code review program with three parallel workstreams inside 30 days: a documentation audit against the 2021 AMA office/outpatient E/M guidelines for CPT 99202–99215, a contract-language review focused on unilateral amendment and recoupment clauses, and a hardened appeals workflow that files under both ERISA (29 CFR 2560.503-1) and the Mental Health Parity and Addiction Equity Act (MHPAEA) where the downcoding pattern hits behavioral E/M harder than medical E/M. Behavioral Health Business first reported that starting July 1, BCBSMT began assessing E/M codes and substituting its own determination of the appropriate level, with losses of $60 to $110 per claim versus what the plan previously paid.
This is not a coding dispute. It is a payer-driven rate compression event dressed up as a coding review. Operators who treat it as a billing problem will lose. Operators who treat it as a contracting, compliance, and parity problem will hold ground.
What BCBSMT is actually doing, and why market share matters
BCBSMT is operated by Health Care Service Corporation (HCSC), the same parent that runs the Illinois, Texas, Oklahoma, and New Mexico Blues. HCSC plans have publicly acknowledged they assess level 4 and 5 E/M codes and, when they determine the code is overcoded, adjust a 99215 down to a 99214 or 99213 and a 99214 down to a 99213. BCBSMT is applying that same logic in Montana against psychiatric and addiction visits, where medical decision-making frequently supports a 99214 or 99215 even when the visit runs shorter than an equivalent primary care encounter.
The math for operators is uncomfortable. In 2024, BCBSMT held a 52% share of the Montana commercial market, per American Medical Association data cited by Behavioral Health Business. In a state with roughly 1.1 million residents, half the commercial book sits with one payer. Terminating is not a real option for most Billings, Missoula, Bozeman, or Great Falls treatment centers. That is exactly why the plan feels comfortable pushing.
The tactical asymmetry: Erin Amato, medical director at Montana Psychiatry and Brain Health Center in Billings, told BHB that “in theory, the downcoded claims can be appealed, but in practice, each appeal takes staff a significant amount of time, documentation, and then follow-up.” That is the point. The plan wins on friction.
The documentation defense: 2021 AMA guidelines, MDM, and psychiatric add-ons
Operators need their clinical directors and billing leads sitting at the same table this quarter. The 2021 AMA office/outpatient E/M revisions eliminated the old history and exam bullet counts for 99202–99215 and rebuilt code selection around medical decision-making (MDM) or total time on the date of the encounter. BCBSMT explicitly recognizes the 2021 AMA guidelines for outpatient office codes, per HCSC-affiliate policy language.
For a psychiatric or SUD visit to defend a 99214, the record should show at least two of the three MDM elements at a moderate level: multiple stable chronic conditions or an acute illness with systemic symptoms; moderate data reviewed (external records, independent historian, prescription drug management); and moderate risk (prescription drug management, decision regarding hospitalization, social determinants limiting diagnosis or treatment). A 99215 requires high MDM, which for behavioral health typically means suicidal ideation with a safety plan, decision regarding hospitalization or crisis stabilization, or drug therapy requiring intensive monitoring for toxicity.
A few operator-side rules the AHS team runs when defending these claims:
- Prescription drug management is not a checkbox. The clinician must name the medication, the decision made (start, stop, titrate, continue with monitoring), and the reasoning behind it.
- Suicidal ideation, homicidal ideation, and withdrawal risk drive risk category. The prescriber should document the assessment, not just a screening score.
- Psychiatric E/M add-ons (90833, 90836, 90838) are billed with the E/M, not instead of it. The clinician must separately document the psychotherapy time, and it cannot overlap the E/M time.
- Time-based coding requires total time on the date of service. Not face-to-face only. Chart review, orders, and coordination count if performed that day.
The AMA’s payer E/M downcoding resource states plainly that “downcoding of CPT codes is not appropriate without review of medical record documentation” and that the AMA vigorously opposes unilateral, arbitrary recoding. That language belongs in every appeal letter.
The contract, the parity argument, and the Montana statutory hooks
Three moves most operators are not making. First, the contract. Pull the BCBSMT participating provider agreement and find the unilateral amendment clause, the payment policy incorporation clause, and the recoupment window. Many HCSC agreements let the plan incorporate payment policies by reference and update them on 30 or 60 days’ notice. If the E/M review program was pushed through as a payment policy update, the contract question is whether notice was proper and whether the amendment materially changes the fee schedule. If it does, some agreements require mutual consent.
Second, Montana statute. The Montana Unfair Claim Settlement Practices Act (33-18-201, MCA) prohibits, among other things, misrepresenting pertinent facts relating to coverage and failing to attempt in good faith to effectuate prompt, fair, and equitable settlement of claims. The Montana Commissioner of Securities and Insurance (CSI) enforces it. A CSI spokesperson told BHB that “CSI is aware of the complaints and is engaging with Blue Cross on the matter.” That is an invitation for operators to file formal complaints with specifics: claim numbers, dates, original code, downcoded code, dollar impact.
Third, MHPAEA. If BCBSMT’s E/M review program produces a materially higher downcoding rate on psychiatric and SUD E/M codes than on medical/surgical E/M codes, that is a nonquantitative treatment limitation (NQTL) disparity. The 2024 MHPAEA Report to Congress, released January 17, 2025, made clear the Departments finalized new MHPAEA rules in September 2024 and continue to prioritize NQTL enforcement, and EBSA’s CAA-related work has directly benefited more than 7.6 million participants across more than 72,000 plans. Operators can file parity complaints with the DOL Employee Benefits Security Administration for ERISA plans and with CMS or the Montana CSI for fully insured plans. The comparative analysis obligation under the Consolidated Appropriations Act, 2021, sits on the plan, not the provider. Make the plan produce it.
Practical sequence AHS recommends: (1) run a 90-day denial and downcoding audit segmented by payer, product line, and code; (2) build a claim-level parity comparison of behavioral vs. Medical E/M downcode rates; (3) file individual appeals with the AMA-style documentation defense and cite 2021 guidelines; (4) escalate a batch complaint to the Montana CSI referencing 33-18-201; (5) preserve the option to file an MHPAEA complaint with DOL if the parity data supports it.
Frequently asked questions
What specifically triggers a BCBSMT E/M downcode on a psychiatric claim?
The plan is reviewing level 4 and level 5 outpatient E/M codes (99214, 99215, and new patient equivalents 99204, 99205) against the 2021 AMA guidelines, then substituting a lower level when it decides the documented MDM or total time does not support the billed level. Psychiatric visits get flagged because MDM is often driven by prescription drug management and risk assessment rather than by extensive data review, which pattern-matching algorithms undervalue.
Can BCBSMT retroactively downcode claims already paid, and what is the recoupment window under Montana law?
Recoupment rights depend on the participating provider agreement and Montana insurance law. Operators should identify the exact recoupment window in their BCBSMT contract (often 12 to 24 months, sometimes longer for suspected fraud) and cross-reference it against Montana prompt-pay and unfair claim settlement provisions under Title 33, Chapter 18. Do not accept an offset letter at face value. Demand the claim-level basis, the policy citation, and the appeal path in writing.
What documentation elements defend a 99214 or 99215 for a psychiatric or SUD visit under 2021 AMA guidelines?
For 99214: moderate MDM built from problems addressed (chronic illness with exacerbation, acute illness with systemic symptoms), data reviewed (external records, independent historian, prescription drug management counts), and moderate risk (prescription drug management, social determinants). For 99215: high MDM, typically anchored in decision regarding hospitalization, suicidal or homicidal ideation with active management, or drug therapy requiring intensive monitoring. Or, use total time on the date of the encounter: 30–39 minutes for 99214, 40–54 minutes for 99215, and document what the time was spent on.
How do we file a parity-based appeal if downcoding disproportionately affects behavioral health E/M codes?
Build the data first. Pull 90 to 180 days of claims, segment behavioral E/M downcode rate against medical/surgical E/M downcode rate on the same plan and product, and quantify the differential. If behavioral is materially higher, that is presumptively an NQTL disparity under MHPAEA. File the appeal citing the plan’s obligation under the Consolidated Appropriations Act, 2021, to produce a comparative analysis, and copy the DOL EBSA Regional Office for ERISA plans or the Montana CSI for fully insured plans.
Should we renegotiate our BCBSMT contract, terminate, or stay in-network, and what is the calculus?
With BCBSMT holding a 52% commercial share in Montana, termination is a nuclear option that most operators cannot survive without a two-year cash runway and a strong out-of-network single-case-agreement strategy. The realistic play is a documented, evidence-based renegotiation: present the downcoding financial impact, the appeal overturn rate, the parity data, and a proposed fee schedule adjustment or a carve-out that removes psychiatric E/M from the review program. Bring the Montana Medical Association and state provider associations into the conversation. Payers move when the political and regulatory cost of standing still exceeds the cost of the concession.
References
- Behavioral Health Business: Providers Fight Downcoding Efforts by BCBS Entity
- American Medical Association: Payer Evaluation and Management (E/M) Downcoding Programs. What You Need to Know
- Experity: BCBS Downcoding Explanation (HCSC-affiliate policy language)
- U.S. Department of Labor: 2024 Mental Health Parity and Addiction Equity Act Report to Congress
- 2024 MHPAEA Report to Congress (full PDF)
- Blue Cross and Blue Shield of Montana: Provider News and Updates
- Montana Department of Administration: BCBSMT Awarded State Plan TPA Contract